118 related articles for article (PubMed ID: 8692493)
1. Gallbladder visualization in 99Tcm-HMPAO autologous white cell scintigraphy.
Neilly JB; Gray HW
Nucl Med Commun; 1996 Mar; 17(3):243-5. PubMed ID: 8692493
[TBL] [Abstract][Full Text] [Related]
2. 99Tcm and 111In leucocyte scintigraphy in inflammatory bowel disease.
Li DJ; Middleton SJ; Wraight EP
Nucl Med Commun; 1992 Dec; 13(12):867-70. PubMed ID: 1465269
[TBL] [Abstract][Full Text] [Related]
3. The significance of low grade right iliac fossa uptake on 99Tcm-HMPAO labelled white cell scans.
Small JH; Wraight EP; Freeman AH; Miles KA
Br J Radiol; 1996 Oct; 69(826):914-9. PubMed ID: 9038526
[TBL] [Abstract][Full Text] [Related]
4. Value of technetium-99m HMPAO-labelled leucocyte scintigraphy as an initial screening test in patients suspected of having inflammatory bowel disease.
Giaffer MH; Tindale WB; Holdsworth D
Eur J Gastroenterol Hepatol; 1996 Dec; 8(12):1195-200. PubMed ID: 8980940
[TBL] [Abstract][Full Text] [Related]
5. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
[TBL] [Abstract][Full Text] [Related]
6. A study of the behaviour of cobalt chloride during the labelling of leukocytes with 99Tcm-HMPAO stabilised in vitro by the addition of cobalt chloride solution.
Prangere T; Bowden AD; Beauchat V; Caulier MT; Ziegels P; Huglo D; Pickett RD; Steinling M
Nucl Med Commun; 1997 Mar; 18(3):258-61. PubMed ID: 9106780
[TBL] [Abstract][Full Text] [Related]
7. Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease.
Allan RA; Sladen GE; Bassingham S; Lazarus C; Clarke SE; Fogelman I
Eur J Nucl Med; 1993 Mar; 20(3):195-200. PubMed ID: 8462606
[TBL] [Abstract][Full Text] [Related]
8. 99Tcm-HMPAO-labelled white blood cell scans to detect acute appendicitis in older patients with an atypical clinical presentation.
Lin WY; Kao CH; Lin HT; Wang YL; Wang SJ; Liu TJ
Nucl Med Commun; 1997 Jan; 18(1):75-8. PubMed ID: 9061706
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of 99Tcm-d,l-HMPAO and 99Tcm-d,l-CBPAO as leukocyte-labelling agents.
Tsai CS; Kao CH; Yeh SJ; Wang SJ
Nucl Med Commun; 1996 Jan; 17(1):76-9. PubMed ID: 8692477
[TBL] [Abstract][Full Text] [Related]
10. 99Tcm-phenylene imine phenol as a potential leukocyte labelling agent.
Huang WT; Lo JM; Kao CH; Wang SJ
Nucl Med Commun; 1997 Jan; 18(1):66-9. PubMed ID: 9061704
[TBL] [Abstract][Full Text] [Related]
11. Abdominal scintigraphy using 99mTc-HMPAO-labelled leucocytes in patients with seronegative spondylarthropathies without clinical evidence of inflammatory bowel disease.
Alonso JC; Lopez-Longo FJ; Lampreave JL; González CM; Vegazo O; Carreño L; Almoguera I
Eur J Nucl Med; 1996 Mar; 23(3):243-6. PubMed ID: 8599954
[TBL] [Abstract][Full Text] [Related]
12. 99Tcm-HMPAO leucocyte scintigraphy in the diagnosis of bone infection.
Moragas M; Lomeña F; Herranz R; García A; Piera C; Muxí A; Bassa P; Catafau A; Pavía A; Setoain J
Nucl Med Commun; 1991 May; 12(5):417-27. PubMed ID: 2067746
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m hexamethylpropyleneamine-oxime-labeled leukocyte scintigraphy in inflammatory bowel disease in children.
Bhargava SA; Orenstein SR; Charron M
J Pediatr; 1994 Aug; 125(2):213-7. PubMed ID: 8040764
[TBL] [Abstract][Full Text] [Related]
14. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
[TBL] [Abstract][Full Text] [Related]
15. The utility of [99mTc]HMPAO-leukocytes for imaging infection.
Peters AM
Semin Nucl Med; 1994 Apr; 24(2):110-27. PubMed ID: 8023168
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of 99Tcm-d,l-HMPAO-labelled leukocyte scintigraphy in the detection of vascular graft infections.
Krznaric E; Nevelsteen A; van Hoe L; de Roo M; Schiepers C; Verbruggen A; Mortelmans L
Nucl Med Commun; 1994 Dec; 15(12):953-60. PubMed ID: 7715894
[TBL] [Abstract][Full Text] [Related]
17. Clinical comparison of 99Tcm-HMPAO labelled leucocytes and 99Tcm-nanocolloid in the detection of inflammation.
Vorne M; Lantto T; Paakkinen S; Salo S; Soini I
Acta Radiol; 1989; 30(6):633-7. PubMed ID: 2698747
[TBL] [Abstract][Full Text] [Related]
18. 99Tcm-HMPAO labelled leucocytes: comparison with 111In-tropolonate labelled granulocytes.
Peters AM; Roddie ME; Danpure HJ; Osman S; Zacharopoulos GP; George P; Stuttle AW; Lavender JP
Nucl Med Commun; 1988 Jun; 9(6):449-63. PubMed ID: 3412733
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous administration of 99Tcm-HMPAO-labelled autologous leukocytes and 111In-labelled non-specific polyclonal human immunoglobulin G in bone and joint infections.
de Lima Ramos PA; Martin-Comin J; Bajén MT; Roca M; Ricart Y; Castell M; Mora J; Puchal R; Ramos M
Nucl Med Commun; 1996 Sep; 17(9):749-57. PubMed ID: 8895902
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory bowel disease activity assessment using technetium-99m-HMPAO leukocytes.
Arndt JW; Grootscholten MI; van Hogezand RA; Griffioen G; Lamers CB; Pauwels EK
Dig Dis Sci; 1997 Feb; 42(2):387-93. PubMed ID: 9052524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
